Psychiatry

814 questions

Question 661Question →

A 23-year-old man is evaluated in the psychiatric outpatient clinic for ongoing management of schizophrenia. His symptoms began seven months ago with persistent auditory hallucinations, persecutory delusions, and severe social withdrawal. He has no significant past medical history, and his initial physical examination, comprehensive metabolic panel, and urine toxicology were unremarkable. The psychiatric care team is establishing a comprehensive, long-term psychopharmacological management plan. Arrange the following clinical steps in the most appropriate standard sequence for the pharmacological management of this patient, assuming he consistently demonstrates an inadequate clinical response to each successive intervention despite appropriate time for titration.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing treatment-resistant schizophrenia is: 1) Initiate a first-line antipsychotic, 2) Verify adherence and optimize the initial dose, 3) Trial a second antipsychotic, 4) Initiate clozapine, and 5) Augment clozapine therapy.
The standard pharmacological management of schizophrenia utilizes a stepwise algorithm designed to balance clinical efficacy with adverse effect profiles. The protocol begins with initiating a standard first- or second-generation antipsychotic. If the patient demonstrates a poor clinical response after 4 to 6 weeks, the physician must first assess medication adherence and ensure the current dosage is optimized before abandoning the trial, as non-adherence is incredibly common. If non-response is firmly confirmed despite adherence, a second trial with a completely different antipsychotic is indicated. Should the patient fail this second adequate trial, they formally meet the criteria for treatment-resistant schizophrenia, establishing clozapine monotherapy as the gold-standard next step. Finally, if the patient exhibits a partial or poor response to an optimized clozapine trial, advanced augmentation strategies (such as adding a second antipsychotic, a mood stabilizer, or utilizing electroconvulsive therapy) are employed.

Step-by-Step Solution

1
Identify the starting point for first-episode psychosis.
Initiation of a first-line oral second-generation antipsychotic.
A standard antipsychotic trial is the primary intervention and standard of care for a new diagnosis of schizophrenia.
2
Determine the immediate next step upon poor initial response.
Assessment of medication adherence and dose optimization.
Non-adherence is the most common cause of perceived treatment failure in psychiatric populations; it must be completely ruled out before safely switching medications.
3
Determine the management step after a confirmed failure of the first drug.
Cross-titration to a second, different oral antipsychotic agent.
Failure of one antipsychotic warrants a trial of a different agent to evaluate responsiveness before considering the patient fully treatment-resistant.
4
Identify the standard management for treatment-resistant schizophrenia.
Initiation of clozapine monotherapy.
Treatment resistance is strictly defined as the failure of at least two adequate antipsychotic trials, making clozapine the gold-standard drug of choice at this stage.
5
Determine the final step for clozapine-refractory symptoms.
Augmentation therapy with ECT or another psychiatric agent.
When an optimized clozapine monotherapy trial fails, augmentation strategies represent the last line of evidence-based pharmacological treatment.

Key Concept

Pharmacological management algorithm for schizophrenia and definition of treatment resistance
Estimated Time:1m 30s
Question 662Question →

Match each clinical presentation or constellation of chronic medical complications to the most likely primary substance use disorder.

Click a left item, then click its matching right item

Items

Ischemic necrosis of the nasal septum, accelerated coronary atherosclerosis, and sudden cardiac death
Cerebellar vermis degeneration, macrocytosis, and dilated cardiomyopathy
Testicular atrophy, severe cystic acne, gynecomastia, and polycythemia
Tricuspid valve endocarditis, focal segmental glomerulosclerosis, and cutaneous track marks
Rampant dental caries, severe skin excoriations due to formication, and marked weight loss

Matches

Show answer & explanation

Answer

The presentations match as follows: Nasal necrosis and coronary atherosclerosis correspond with Cocaine use disorder; Cerebellar degeneration and dilated cardiomyopathy with Severe alcohol use disorder; Testicular atrophy and polycythemia with Anabolic-androgenic steroid abuse; Tricuspid endocarditis and focal segmental glomerulosclerosis with Intravenous heroin use; and Dental caries and severe skin excoriations with Methamphetamine use disorder.
Each substance has a unique profile of long-term medical complications based on its specific mechanism of action, route of administration, and direct toxic effects on target organ systems.

Step-by-Step Solution

1
Analyze the first clinical presentation: nasal septal necrosis and coronary atherosclerosis.
Identified as complications of cocaine use.
Cocaine causes significant localized vasoconstriction (septal necrosis) and systemic sympathetic activation, leading to rapid atherosclerosis and vasospasm.
2
Analyze the second presentation: cerebellar degeneration and dilated cardiomyopathy.
Identified as complications of chronic alcohol use.
Alcohol is a direct toxin to cerebellar tissue and cardiac myocytes, leading to truncal ataxia and non-ischemic heart failure.
3
Analyze the third presentation: testicular atrophy, gynecomastia, and polycythemia.
Identified as systemic effects of anabolic-androgenic steroids.
Exogenous steroids cause negative feedback on endogenous testosterone production, aromatization to estrogen, and increased red blood cell production.
4
Analyze the fourth presentation: tricuspid endocarditis and focal segmental glomerulosclerosis.
Identified as specific complications of intravenous heroin use.
IV drug use introduces bacteria directly into the venous return to the right heart, and heroin specifically damages renal podocytes causing FSGS.
5
Analyze the fifth presentation: rampant dental caries and severe skin excoriations.
Identified as physical complications of methamphetamine use.
Methamphetamine causes severe bruxism and dry mouth ('meth mouth') along with highly characteristic tactile hallucinations (formication or 'meth bugs').

Key Concept

Recognizing the distinct chronic medical complications and physical exam findings associated with long-term use of specific substances is crucial for accurate diagnosis and holistic patient management.
Estimated Time:1m 30s
Question 663Question →

A 24-year-old woman is newly diagnosed with schizophrenia after presenting with persistent auditory hallucinations and persecutory delusions. The treatment team outlines a comprehensive, stepwise pharmacological management plan for her condition, anticipating the possibility of treatment resistance at each stage. Arrange the following therapeutic steps in the standard sequential order they should be implemented, assuming the patient continues to have severe, unrelenting symptoms despite documented adherence to each prior intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Initial trial of risperidone monotherapy, 2) Trial of aripiprazole monotherapy, 3) Initiation of clozapine, 4) Augmentation with ECT.
The correct algorithm for managing schizophrenia begins with a trial of a first-line antipsychotic (e.g., risperidone). If the initial trial fails, a second trial with a different antipsychotic (e.g., aripiprazole) is indicated. Treatment-resistant schizophrenia is defined by the failure of at least two adequate trials of different antipsychotics; at this stage, clozapine is the treatment of choice. Finally, if the patient continues to experience refractory symptoms on an adequate dose of clozapine, augmentation strategies such as ECT are utilized.

Step-by-Step Solution

1
Identify the appropriate initial therapy for a newly diagnosed patient with schizophrenia.
The first step is a trial of a first-line antipsychotic, such as oral risperidone monotherapy.
Second-generation antipsychotics have favorable efficacy and side-effect profiles for initial treatment.
2
Determine the next step if the initial 6-week trial is ineffective.
The patient should be switched to a different first- or second-generation antipsychotic, such as oral aripiprazole monotherapy.
Failure of one antipsychotic does not indicate treatment resistance. A second, different monotherapy trial is required.
3
Recognize the criteria for treatment-resistant schizophrenia.
After failing two adequate trials of different antipsychotics, the patient should be prescribed clozapine.
Clozapine is uniquely effective for treatment-resistant schizophrenia and reducing suicidal behavior, despite requiring strict hematologic monitoring.
4
Formulate a plan for clozapine refractoriness.
If symptoms persist despite an adequate clozapine trial, the final step is augmentation with electroconvulsive therapy (ECT) or a second antipsychotic.
ECT is a well-established, evidence-based augmentation strategy for clozapine-resistant schizophrenia.

Key Concept

The stepwise pharmacological management of schizophrenia involves sequential trials of different antipsychotics, followed by clozapine for treatment resistance, and finally clozapine augmentation strategies.
Estimated Time:1m 0s
Question 664Question →

A 45-year-old woman with a history of severe alcohol use disorder is admitted to the inpatient psychiatric unit for medical detoxification. She reports that her last drink was 12 hours ago. On examination, she exhibits bilateral hand tremors, mild tachycardia, diaphoresis, and anxiety. Arrange the following clinical management steps in the most appropriate chronological sequence for this patient's comprehensive care, proceeding from initial acute stabilization to long-term relapse prevention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with a standardized assessment of withdrawal severity, followed by symptom-triggered benzodiazepine administration, ongoing monitoring through the high-risk period for complicated withdrawal, initiation of maintenance pharmacotherapy upon stabilization, and finally, integration into outpatient psychosocial support at discharge.
Effective management of alcohol use disorder requires a phased approach. The sequence must respect the clinical timeline of withdrawal. First, acute severity is quantified to guide targeted benzodiazepine therapy. Because complicated withdrawal (delirium tremens) peaks later (48-96 hours), monitoring must continue even after initial symptoms improve. Only after acute physiological stability is achieved should long-term maintenance medications (like naltrexone) be started, culminating in structured outpatient psychiatric discharge planning.

Step-by-Step Solution

1
Assess current withdrawal severity
Obtain an objective baseline score (e.g., CIWA-Ar).
Provides a standardized metric to safely and accurately guide the immediate pharmacological intervention.
2
Administer symptom-triggered benzodiazepines
Suppression of acute withdrawal manifestations.
Treats early withdrawal symptoms (tremors, anxiety) and prevents the progression to complicated withdrawal phenomena like seizures.
3
Monitor through the critical 48-96 hour window
Safe passage through the highest risk period for complicated withdrawal.
Ensures patient safety during the timeframe when life-threatening delirium tremens typically emerges.
4
Initiate maintenance pharmacotherapy
Establishment of an anti-craving or relapse-prevention medical regimen.
Reduces the biological drive to drink once the patient is medically cleared of acute autonomic instability.
5
Coordinate outpatient support
Establishment of a long-term care plan.
Provides the necessary psychosocial scaffolding and peer support required for durable sobriety after leaving the controlled inpatient environment.

Key Concept

The comprehensive sequencing of Alcohol Use Disorder treatment: from acute, symptom-triggered medical detoxification to the implementation of long-term maintenance pharmacotherapy and psychosocial support.
Estimated Time:1m 30s
Question 665Question →

A 28-year-old woman is brought to the emergency department by emergency medical services after she was found severely agitated and combative outside a nightclub. Her friends report that she consumed an unknown "party pill" a few hours ago. The patient has a history of major depressive disorder with past hypomanic episodes, for which she was recently prescribed sertraline by a new primary care physician. She also has a history of opioid use disorder and has been stable on methadone maintenance therapy for two years.

On presentation, she is hallucinating, claiming that "angels are commanding her to fly." Vital signs are temperature 39.4°C (102.9°F), blood pressure 178/108 mm Hg, pulse 142/min, and respirations 24/min. Physical examination reveals marked diaphoresis, mydriasis, and bilateral continuous ankle clonus with generalized hyperreflexia.

Laboratory studies show:
Thyroid-stimulating hormone (TSH): 0.1 µU/mL (normal: 0.4–4.0 µU/mL)
Free thyroxine (T4): 1.3 ng/dL (normal: 0.9–1.7 ng/dL)
Urine toxicology screen is positive for methadone but negative for amphetamines, cocaine, and phencyclidine (PCP).

Which of the following is the most likely diagnosis for this patient's acute presentation?

Show answer & explanation

Answer: Substance-induced serotonin toxicity

Answer

Substance-induced serotonin toxicity
The patient's clinical picture of altered mental status, profound autonomic instability (hyperthermia, hypertension, tachycardia), and distinct neuromuscular hyperactivity (hyperreflexia, continuous ankle clonus) forms the classic diagnostic triad of serotonin toxicity (serotonin syndrome). This life-threatening condition was precipitated by the ingestion of an illicit serotonergic substance, such as MDMA (ecstasy) or a synthetic cathinone, which frequently elude routine urine amphetamine screens. The patient's risk was heavily compounded by her baseline use of sertraline (an SSRI) and methadone, both of which increase synaptic serotonin levels. In cases of acute substance-induced toxidromes, identifying the specific interaction between illicit agents and prescribed medications is critical for accurate diagnosis and management.

Step-by-Step Solution

1
Evaluate the patient's vital signs and physical examination for specific toxidrome characteristics.
The patient exhibits severe autonomic instability (temperature 39.4°C, marked hypertension, tachycardia) and neuromuscular hyperactivity (continuous ankle clonus, hyperreflexia).
Identifying the specific pattern of sympathetic overactivity and reflex abnormalities is the critical first step in differentiating toxicologic emergencies.
2
Synthesize the patient's medication history with the acute presentation.
The patient is actively taking sertraline (an SSRI) and methadone (a weak serotonin reuptake inhibitor), both of which increase baseline serotonergic tone.
Polypharmacy often lowers the threshold for drug-induced toxicities, making the patient highly vulnerable to severe pharmacological interactions.
3
Analyze the potential impact of the acutely ingested illicit substance in this context.
The ingested 'party pill' is likely a serotonergic amphetamine analog (such as MDMA/ecstasy), which precipitates massive serotonin release and frequently escapes detection on standard amphetamine urine screens.
Combining a powerful serotonin-releasing illicit agent with baseline reuptake inhibitors triggers life-threatening serotonin syndrome.
4
Rule out competing diagnoses based on lab results and clinical criteria.
Normal free T4 rules out thyroid storm; the presence of clonus and severe hyperthermia definitively rules out isolated opioid withdrawal or a primary manic/psychotic episode.
It is necessary to systematically exclude primary psychiatric and endocrine emergencies before finalizing a toxicologic diagnosis.

Key Concept

Diagnosis of substance-induced toxidromes and recognition of life-threatening pharmacological interactions, specifically serotonin syndrome triggered by MDMA combined with SSRIs.
Estimated Time:2m 0s
Question 666Question →

During a routine visit to an outpatient clinic, a 29-year-old woman reports a 2-month history of persistent sadness, tearfulness, and profound fatigue. She states she has lost interest in reading and hiking, activities she previously enjoyed every weekend. The patient notes she has been waking up at 3 AM daily and is unable to fall back asleep. She has lost 4 kg (8.8 lb) over this period without actively dieting. She denies any substance use or suicidal ideation. She has no significant past medical history and currently takes no medications. Her physical examination is unremarkable. The patient requests to be started on a medication to help her mood, noting that a family member had significant improvement with fluoxetine. Which of the following is the most appropriate next step in the clinical evaluation of this patient?

Show answer & explanation

Answer: Ascertain if the patient has experienced prior periods of abnormally elevated mood and increased goal-directed activity.

Answer

The most appropriate next step is to ascertain if the patient has experienced prior periods of abnormally elevated mood and increased goal-directed activity.
The correct action is to screen for a history of abnormally elevated mood and increased goal-directed activity. This patient presents with a classic major depressive episode. However, before prescribing any antidepressant monotherapy (such as the requested fluoxetine), it is mandatory to screen for a past history of manic or hypomanic episodes. If a patient has a history of mania or hypomania, the underlying diagnosis is bipolar disorder. Prescribing an antidepressant without a concurrent mood stabilizer in a patient with bipolar disorder carries a significant risk of inducing a manic episode, commonly known as a manic switch.

Step-by-Step Solution

1
Analyze the patient's presenting clinical symptoms.
The patient meets the diagnostic criteria for a major depressive episode based on low mood, anhedonia, early morning awakening, weight loss, and duration of 2 months.
To establish the current clinical syndrome requiring management.
2
Evaluate the patient's request for treatment.
The patient is requesting an antidepressant (fluoxetine) for her depressive symptoms.
To determine the potential risks and required screening before fulfilling the treatment request.
3
Determine the necessary safety screening prior to initiating antidepressant pharmacotherapy.
Screening for a history of manic or hypomanic episodes must be performed to differentiate unipolar depression from bipolar depression.
Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a dangerous manic switch.

Key Concept

Before initiating antidepressant monotherapy for a major depressive episode, clinicians must screen for a history of mania or hypomania to rule out bipolar disorder and prevent antidepressant-induced manic switching.
Question 667Question →

A 58-year-old woman is evaluated in the psychiatric clinic for a severe depressive episode characterized by profound sadness, anhedonia, early morning awakening, and significant weight loss. Over the course of the following year, her major depressive disorder proves difficult to manage, requiring a progressive escalation of her treatment plan due to varying degrees of treatment resistance. Her course ultimately culminates in a severe decompensation requiring urgent intervention. Arrange the following therapeutic steps in the most appropriate chronological sequence according to standard evidence-based treatment algorithms for major depressive disorder, from her initial presentation to the management of her final life-threatening deterioration.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for escalating treatment in major depressive disorder is: 1) Initiation of an SSRI at a standard dose, 2) Dose titration of the SSRI following a partial response, 3) Augmentation with an atypical antipsychotic after non-remission on a maximized dose, and 4) Electroconvulsive therapy (ECT) upon the development of severe psychotic features and food refusal.
The standard treatment algorithm for major depressive disorder begins with monotherapy using a first-line agent (SSRI, SNRI, bupropion, or mirtazapine). If the patient exhibits a partial response after an adequate trial (typically 4-6 weeks), the initial step is dose optimization. If the patient continues to experience significant residual symptoms despite an optimized dose, augmentation with another agent (such as an atypical antipsychotic) or switching to a different antidepressant class is indicated. Finally, for severe major depressive disorder complicated by life-threatening features (such as refusal to eat, acute active suicidality, or psychotic features), urgent electroconvulsive therapy (ECT) is the treatment of choice.

Step-by-Step Solution

1
Identify the initial presentation of uncomplicated major depressive disorder.
The first step is initiating a first-line agent, such as an SSRI.
SSRIs are standard first-line therapies due to their favorable side-effect profiles and established efficacy.
2
Evaluate the management of a partial clinical response after an initial 4-week trial.
The next step is to maximize the dose of the current SSRI.
Dose optimization is the standard protocol when a patient shows partial improvement and tolerates the medication well, before switching or augmenting.
3
Determine the strategy for treatment-resistant depression when the maximized SSRI fails to achieve remission.
The subsequent step is augmentation with another agent, such as an atypical antipsychotic.
Augmentation or switching classes is indicated when an adequate trial of a maximized first-line agent remains ineffective.
4
Recognize the emergence of life-threatening and psychotic features.
The final step in this sequence is inpatient admission for ECT.
ECT is the gold-standard, rapid-acting treatment for depression complicated by mood-congruent delusions and severe food refusal.

Key Concept

Stepped-care pharmacological management and indications for electroconvulsive therapy (ECT) in major depressive disorder.
Question 668Question →

A 21-year-old man is brought to the outpatient psychiatric clinic by his mother. For the past 3 weeks, he has been spending up to 6 hours a day repeatedly checking locks, counting backwards from 100, and washing his hands. He states he must perform these actions because he is tormented by intrusive, unwanted thoughts that his family will die in a house fire if he does not. He recognizes that these thoughts are irrational but feels immense, paralyzing anxiety if he attempts to stop the behaviors. His psychiatric history is notable for a hospitalization at age 19 for a 2-week episode characterized by a decreased need for sleep, grandiosity, and pressured speech, which was preceded by a major depressive episode. He is currently unmedicated. At the end of the clinical assessment, the patient explicitly requests that his medical information remain private. His mother, however, demands to be informed of the diagnosis and treatment plan, stating she has a right to know because he lives in her home and is covered under her health insurance. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate exposure and response prevention therapy and maintain patient confidentiality.

Answer

The most appropriate step is to initiate exposure and response prevention therapy while honoring the patient's request to maintain medical confidentiality.
The correct answer addresses both the optimal management of Obsessive-Compulsive Disorder (OCD) in a complex psychiatric context and the ethical imperative of patient privacy. The patient's intrusive thoughts and compensatory repetitive behaviors confirm a diagnosis of OCD. While selective serotonin reuptake inhibitors (SSRIs) are a typical first-line pharmacotherapy for OCD, this patient has a clear history of Bipolar I disorder (evidenced by a prior manic episode requiring hospitalization). SSRI monotherapy in patients with bipolar disorder carries a significant risk of precipitating a manic switch. Therefore, Exposure and Response Prevention (ERP) therapy, a specialized form of cognitive-behavioral therapy, is the safest and most effective first-line monotherapy for his OCD. Additionally, competent adult patients have a fundamental right to medical confidentiality. Provision of housing or health insurance by a parent does not grant legal access to protected health information. The physician must respect the patient's explicit request for privacy.

Step-by-Step Solution

1
Identify the primary acute psychiatric diagnosis.
The patient has Obsessive-Compulsive Disorder (OCD).
The presence of time-consuming, distressing intrusive thoughts (obsessions) and compensatory repetitive behaviors (compulsions) with preserved insight confirms OCD.
2
Evaluate the patient's psychiatric history for comorbidities.
The patient has an underlying diagnosis of Bipolar I disorder.
The history of a 2-week episode of grandiosity, decreased sleep, and pressured speech requiring hospitalization meets the criteria for a manic episode.
3
Determine the safest initial management strategy for OCD in this context.
Select Exposure and Response Prevention (ERP) therapy.
Standard first-line pharmacotherapy for OCD (SSRI monotherapy) is contraindicated in Bipolar I disorder due to the risk of inducing mania. ERP is a highly effective, non-pharmacologic first-line treatment that carries no risk of manic switch.
4
Apply core ethical principles regarding patient privacy.
Refuse the mother's request for disclosure.
A competent 21-year-old adult holds the fundamental right to medical confidentiality, which is not negated by parental financial support, shared housing, or dependent insurance coverage.

Key Concept

Management of OCD in patients with comorbid Bipolar I disorder requires avoiding SSRI monotherapy to prevent manic switch, making Exposure and Response Prevention (ERP) therapy the safest first-line intervention. Competent adult patients retain the right to confidentiality regardless of financial dependence.
Question 669Question →

A 31-year-old woman, gravida 2, para 1, at 28 weeks gestation is evaluated in the outpatient clinic for severe insomnia. Over the past month, she has been unable to fall asleep because of an uncomfortable, aching sensation deep within her calves. She states, "I feel an overwhelming urge to move my legs to make the feeling stop." These symptoms occur exclusively when she lies down to rest at night and improve significantly when she gets out of bed and paces around the house. Her medical history includes generalized anxiety disorder, which has been stable on sertraline for the past two years. Her prenatal course has been uncomplicated, and vital signs are normal. Neurological examination reveals normal muscle strength, tone, and deep tendon reflexes in the lower extremities. Which of the following is the most appropriate initial step in the evaluation or management of this patient's sleep complaint?

Show answer & explanation

Answer: Measure serum ferritin concentration

Answer

The most appropriate initial step is to measure the serum ferritin concentration.
The correct answer is to measure the serum ferritin concentration. This patient's clinical presentation—an irresistible urge to move her legs that worsens at night and during rest, and improves with movement—is diagnostic of Restless Legs Syndrome (RLS). RLS is a sensorimotor sleep-wake disorder that can be primary or secondary. Secondary causes are common and include pregnancy, uremia, diabetes mellitus, and medications (especially SSRIs, SNRIs, and antiemetics). Crucially, depleted iron stores in the central nervous system play a major role in the pathophysiology of RLS. Therefore, measuring a serum ferritin level is the standard initial step in evaluation for all patients with new-onset RLS, even if a complete blood count shows no overt anemia. A ferritin level below 75 ng/mL warrants iron supplementation.

Step-by-Step Solution

1
Analyze the patient's symptoms based on timing and alleviating factors.
The irresistible urge to move the legs, worsening at rest and at night, and relief with movement indicate a clinical diagnosis of Restless Legs Syndrome (RLS).
Accurate diagnosis of the sleep-wake disorder guides appropriate workup and prevents unnecessary testing.
2
Identify potential secondary causes or exacerbating factors present in the patient's history.
The patient is pregnant and taking an SSRI (sertraline), both of which are strong risk factors for developing or worsening RLS.
Understanding the multifactorial etiology of RLS helps in managing reversible causes.
3
Determine the standard initial diagnostic workup for new-onset RLS.
Evaluate iron stores by measuring a serum ferritin concentration.
Iron deficiency, even without overt anemia, is a primary reversible cause of RLS, and central nervous system iron depletion contributes to the disorder's pathophysiology.

Key Concept

The diagnosis of Restless Legs Syndrome is primarily clinical. All patients with new-onset symptoms should have their serum ferritin concentration checked, as iron deficiency is a common, reversible cause of the disorder.
Estimated Time:1m 15s
Question 670Question →

A 34-year-old female with schizoaffective disorder is admitted to the hospital for intravenous antibiotic therapy for a complicated cellulitis. Her psychiatric symptoms have been well controlled for the past three years on a stable dose of clozapine. She typically smokes one and a half packs of cigarettes daily but is currently in a strict smoke-free inpatient unit; a transdermal nicotine patch was prescribed on admission to prevent withdrawal. Her other home medications include a combined oral contraceptive pill and ibuprofen as needed. On hospital day 4, the patient becomes progressively lethargic and develops significant sialorrhea. Later that evening, she experiences a generalized tonic-clonic seizure. Her vital signs are temperature 37.1°C (98.8°F), blood pressure 110/70 mm Hg, pulse 92/min, and respirations 14/min. Laboratory studies show a normal basic metabolic panel, and her white blood cell count is 8,500/mm³. Which of the following is the most likely pharmacological explanation for this patient's acute neurological presentation?

Show answer & explanation

Answer: Decreased hepatic drug clearance due to the removal of a cytochrome P450 inducer

Answer

The correct underlying mechanism is decreased hepatic drug clearance due to the removal of a cytochrome P450 inducer.
The correct answer describes decreased hepatic drug clearance due to the removal of a cytochrome P450 inducer. This patient is exhibiting textbook signs of clozapine toxicity, which classically presents with severe sedation (lethargy), sialorrhea (excessive drooling), and dose-dependent generalized tonic-clonic seizures. Clozapine is primarily metabolized by the cytochrome P450 1A2 (CYP1A2) hepatic enzyme. Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs), which are potent inducers of CYP1A2. When a heavy smoker is abruptly placed in a smoke-free environment (such as an inpatient hospital admission), the induction of CYP1A2 rapidly diminishes. This leads to a significant decrease in the clearance of clozapine, causing serum levels to rise precipitously into toxic ranges, even though the prescribed medication dose remained unchanged.

Step-by-Step Solution

1
Analyze the patient's acute symptoms.
The patient exhibits lethargy, sialorrhea (excessive drooling), and a generalized tonic-clonic seizure.
Identifying the clinical toxidrome is the first step to pinpointing the offending agent.
2
Correlate the toxidrome with the patient's medication list.
The symptoms represent classic dose-dependent toxicities of clozapine.
Clozapine side effects include severe sedation, prominent sialorrhea, and a dose-dependent reduction in the seizure threshold.
3
Identify the trigger for the sudden onset of toxicity in a previously stable patient.
The patient is a heavy smoker who was abruptly forced to cease smoking upon hospital admission.
Changes in environmental exposures, particularly smoking, can drastically alter the metabolism of psychiatric medications.
4
Determine the pharmacokinetic mechanism connecting smoking cessation to clozapine levels.
Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs) that strongly induce CYP1A2, the primary enzyme that metabolizes clozapine.
Abrupt smoking cessation leads to a rapid loss of CYP1A2 induction, causing clozapine metabolism to slow down and serum levels to spike, precipitating toxicity despite an unchanged oral dose.

Key Concept

Polycyclic aromatic hydrocarbons in tobacco smoke strongly induce CYP1A2. Abrupt smoking cessation in patients taking CYP1A2 substrates like clozapine leads to decreased clearance, elevated serum levels, and potentially life-threatening dose-dependent toxicity.
Question 671Question →

Emergency medical personnel transport an unresponsive 27-year-old male to the resuscitation bay after bystanders discovered him collapsed in a public restroom. Upon initial assessment, the patient is deeply obtunded and making no spontaneous movements. Hemodynamic monitoring reveals a blood pressure of 105/60 mm Hg and a heart rate of 55/min. His respiratory rate is markedly depressed at 5/min with shallow, irregular excursions, and pulse oximetry indicates an oxygen saturation of 78% on room air. Physical examination is notable for symmetric, 1-mm miotic pupils and cyanosis of the lips. Paramedics note that an empty syringe and a bent spoon were recovered at the scene. Arrange the following clinical interventions in the most appropriate chronological sequence for managing this patient's acute presentation and subsequent transition to recovery.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with basic life support (bag-mask ventilation), followed by antidote administration (naloxone), medical observation for re-sedation, psychiatric evaluation for medication-assisted treatment, and concludes with harm reduction (take-home naloxone) at discharge.
The correct sequence of management for a patient presenting with an acute opioid overdose emphasizes the standard 'ABCs' (Airway, Breathing, Circulation) of resuscitation, followed by targeted antidote therapy, necessary medical observation due to pharmacokinetic mismatches, and finally, psychiatric and addiction medicine interventions. Hypoxia is the most immediate life threat, making ventilation the first step. Naloxone follows to reverse the toxicity. Because naloxone wears off faster than most opioids, an observation period is mandatory. Only after the patient is completely medically cleared can they be evaluated for medication-assisted treatment and subsequently discharged with harm-reduction tools.

Step-by-Step Solution

1
Assess airway and breathing, and initiate bag-mask ventilation with supplemental oxygen.
The patient's severe hypoxia is addressed and oxygen saturation begins to improve.
In any unresponsive patient with severe respiratory depression, securing the ABCs (Airway, Breathing, Circulation) takes absolute immediate precedence to prevent hypoxic brain injury, even when the suspected diagnosis is clear.
2
Administer the opioid antagonist naloxone via intravenous or intramuscular route.
The competitive antagonist displaces the opioid from mu-receptors, rapidly reversing central respiratory depression and restoring spontaneous breathing.
Once the airway is temporarily supported, the specific antidote must be given to reverse the underlying toxicologic cause of the coma and hypoventilation.
3
Monitor the patient continuously in the emergency setting for 4 to 6 hours.
The clinical team ensures the patient remains alert and spontaneously breathing as the initial dose of naloxone is metabolized.
Naloxone's duration of action is significantly shorter than that of most abused opioids. This creates a high risk for recurrent, potentially fatal respiratory depression if the patient is prematurely discharged or unobserved.
4
Perform a comprehensive substance use evaluation and discuss options for medication for opioid use disorder (MOUD).
The patient is engaged in addiction treatment planning, such as potential induction of buprenorphine or referral for methadone maintenance.
Psychiatric and addiction evaluation is only safe and effective once the patient is medically cleared and awake. Initiating MOUD reduces the risk of future relapses.
5
Dispense a take-home naloxone kit and coordinate a warm handoff to an outpatient treatment program upon discharge.
The patient leaves the acute care facility with lifesaving medication and a concrete plan for ongoing recovery support.
Harm reduction strategies and direct linkages to care are essential final steps before a patient transitions out of the acute care setting to prevent recurrent morbidity and mortality.

Key Concept

In suspected opioid overdose, airway and breathing support always precedes or occurs simultaneously with naloxone administration; subsequent management requires observation for re-sedation due to naloxone's short half-life, followed by initiating treatment for the underlying opioid use disorder.
Question 672Question →

A 35-year-old woman is brought to the psychiatric clinic by her husband due to behavioral changes over the past 3 months. Her husband reports that she recently took a sudden leave of absence from her job as a middle school teacher. During the interview, the patient states she had to stop teaching because the school's intercom system was intercepting her private thoughts and broadcasting them to the students. She also reports hearing two distinct male voices discussing her daily activities. These symptoms began precisely 3 months ago, shortly after she moved to a new neighborhood, and have been present continuously since. She has no history of depressive or manic episodes, and her medical history is unremarkable. A urine toxicology screen is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder is the correct diagnosis because the patient has active-phase psychotic symptoms lasting between 1 and 6 months.
The correct answer is schizophreniform disorder. The patient presents with two Criterion A symptoms of schizophrenia (delusions and auditory hallucinations) resulting in functional impairment. The critical differentiating factor is the duration of her symptoms. In the DSM-5, the distinction between brief psychotic disorder, schizophreniform disorder, and schizophrenia is strictly based on time. Symptoms lasting at least 1 day but less than 1 month constitute brief psychotic disorder. Symptoms lasting between 1 month and 6 months constitute schizophreniform disorder. Symptoms persisting for 6 months or longer are required for a diagnosis of schizophrenia. Because this patient's symptoms have been present for exactly 3 months, schizophreniform disorder is the only appropriate diagnosis.

Step-by-Step Solution

1
Identify the patient's primary symptoms and their impact.
The patient has delusions (thought broadcasting) and auditory hallucinations leading to significant functional impairment (leave of absence from work).
Establishing the presence of active-phase psychotic symptoms (Criterion A for schizophrenia) is the first step in the diagnostic algorithm.
2
Determine the exact duration of the psychotic symptoms.
The symptoms began precisely 3 months ago and have been continuous.
Duration is the primary differentiating factor among primary psychotic disorders.
3
Rule out mood disorders, substance use, and general medical conditions.
The patient has no mood history, unremarkable medical history, and negative toxicology, ruling out schizoaffective disorder, bipolar disorder, major depression with psychotic features, and substance-induced psychosis.
Psychiatric diagnoses are made after ruling out secondary causes and concurrent major mood episodes.
4
Apply the duration criteria to the remaining primary psychotic disorders.
A duration of 3 months is greater than 1 month (ruling out brief psychotic disorder) but less than 6 months (ruling out schizophrenia), leading to a diagnosis of schizophreniform disorder.
To synthesize the clinical presentation with strict DSM-5 timeframes.

Key Concept

The primary differentiating factor between brief psychotic disorder, schizophreniform disorder, and schizophrenia is the duration of symptoms.
Question 673Question →

A 21-year-old college junior is brought to the student health clinic by his roommate. The roommate reports that for the past 6 weeks, the patient has been behaving unusually, such as wrapping his laptop in aluminum foil and claiming that foreign intelligence agents are tracking his brainwaves. During the interview, the patient appears visibly guarded, avoids eye contact, and frequently pauses mid-sentence as if listening to an unseen presence. When contacted, the patient's parents state that he was an outgoing and high-achieving student until approximately 8 months ago. At that time, he abruptly quit the university track team, withdrew from social activities, and began speaking in a monotonous tone with minimal facial expressivity. The parents note his sleep and appetite have remained normal, and he has consistently denied feeling sad or hopeless. A comprehensive metabolic panel and a urine toxicology screen show no abnormalities. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophrenia

Answer

Schizophrenia
The correct diagnosis is schizophrenia. The diagnostic criteria for schizophrenia require the continuous signs of the disturbance to persist for at least 6 months. This 6-month period must include at least 1 month of active-phase symptoms (delusions, hallucinations, disorganized speech, disorganized behavior, or negative symptoms) and may include periods of prodromal or residual symptoms. In this vignette, the patient has experienced active positive symptoms (delusions of being tracked, auditory hallucinations) for 6 weeks. However, his illness began 8 months ago with an abrupt decline in functioning and the onset of prominent negative symptoms (social withdrawal, alogia, flat affect). Because the total duration of his illness (prodromal phase plus active phase) is 8 months, he meets the criteria for schizophrenia.

Step-by-Step Solution

1
Identify the active psychotic symptoms and their duration.
The patient has experienced delusions of persecution and likely auditory hallucinations for the past 6 weeks.
This establishes the presence of an active psychotic phase lasting at least 1 month, fulfilling Criterion A for schizophrenia spectrum disorders.
2
Identify any preceding prodromal symptoms and calculate the total duration of illness.
The patient exhibited social withdrawal, monotonous speech (alogia), and minimal facial expressivity (flat affect) starting 8 months ago.
DSM-5 criteria require counting prodromal, active, and residual phases toward the total duration of the disturbance.
3
Compare the total illness duration against diagnostic timeline criteria.
The total duration is 8 months. Schizophreniform disorder requires a duration of 1 to 6 months, whereas schizophrenia requires a duration of greater than 6 months.
Because the continuous signs of the disturbance exceed 6 months, the correct diagnosis is schizophrenia.

Key Concept

The diagnosis of schizophrenia requires continuous signs of the disturbance (including prodromal, active, and residual phases) for at least 6 months, whereas schizophreniform disorder is diagnosed when the total duration is between 1 and 6 months.
Question 674Question →

Match each polysomnography (PSG) or Multiple Sleep Latency Test (MSLT) finding to the most appropriate sleep-wake disorder diagnosis.

Click a left item, then click its matching right item

Items

Sustained electromyographic (EMG) tone on chin leads during epochs of rapid eye movements and low-voltage, mixed-frequency EEG.
Mean sleep latency of 6 minutes and two sleep-onset REM periods (SOREMPs) across five daytime nap opportunities.
Recurrent episodes of absent airflow lasting >10 seconds without associated thoracic or abdominal respiratory excursions.
Apnea-hypopnea index of 25 events per hour characterized by absent airflow with paradoxical inward rib cage and outward abdominal movements.

Matches

Show answer & explanation

Answer

Sustained EMG tone during REM matches REM Sleep Behavior Disorder; early REM onset and shortened sleep latency on MSLT matches Narcolepsy; absent airflow without respiratory effort matches Central Sleep Apnea; and absent airflow with paradoxical respiratory effort matches Obstructive Sleep Apnea.
Polysomnography (PSG) and the Multiple Sleep Latency Test (MSLT) provide objective measures to diagnose specific sleep-wake disorders. REM sleep behavior disorder is characterized by a lack of normal muscle atonia during REM sleep, observed as sustained EMG tone. Narcolepsy is objectively diagnosed on MSLT by a sleep latency of 8 minutes or less and 2 or more SOREMPs. Sleep apnea syndromes are differentiated by respiratory effort during apneic events: effort is present in obstructive sleep apnea (causing paradoxical chest and abdominal movements) and absent in central sleep apnea.

Step-by-Step Solution

1
Analyze the first finding of sustained EMG tone during REM sleep.
This indicates a loss of normal REM sleep muscle atonia.
Loss of REM atonia is the key diagnostic finding for REM sleep behavior disorder, explaining dream enactment behaviors.
2
Analyze the MSLT finding of a 6-minute sleep latency with two SOREMPs.
These findings show objective hypersomnolence and premature entry into REM sleep.
These are the pathognomonic diagnostic criteria for narcolepsy.
3
Analyze the finding of absent airflow without thoracic or abdominal excursions.
This indicates an absence of respiratory drive during the apneic event.
A lack of respiratory effort during apneic episodes defines central sleep apnea.
4
Analyze the finding of absent airflow with paradoxical inward rib cage and outward abdominal movements.
This indicates continued respiratory effort against a closed upper airway.
Respiratory effort against an obstructed airway is the hallmark finding of obstructive sleep apnea.

Key Concept

Differentiating sleep-wake disorders based on pathognomonic polysomnography and MSLT findings
Question 675Question →

Seeking relief from pervasive, uncontrollable worry, a 38-year-old female executive presents to a new psychiatrist. For the last eight months, she has been continuously anxious about her career stability, her children's academic performance, and her personal health. This worry has led to chronic muscle tension, fatigue, and disrupted sleep. Her past medical records reveal a psychiatric hospitalization in her twenties for a discrete episode characterized by euphoric mood, hypersexuality, and a complete lack of sleep for eight consecutive days. Three weeks ago, a different provider prescribed her phenelzine for her anxiety. She took the medication for two weeks but abruptly stopped it three days prior to this appointment due to intolerable orthostatic hypotension. The current physician establishes a diagnosis of generalized anxiety disorder. Which of the following are appropriate components of this patient's management plan? (Select 2 answers)

Select all that apply

Show answer & explanation

Answer: Referral for cognitive-behavioral therapy emphasizing cognitive restructuring and relaxation techniques; Avoidance of all serotonergic medications for at least 11 additional days

Answer

The appropriate management steps involve referring the patient for cognitive-behavioral therapy and avoiding serotonergic medications for at least 11 additional days.
The correct management plan must address the patient's generalized anxiety disorder while safely navigating her complex psychiatric and pharmacological history. First, cognitive-behavioral therapy (CBT) is a first-line, evidence-based treatment for GAD that carries no risk of pharmacological interactions or manic induction. Second, the patient recently discontinued phenelzine, an irreversible monoamine oxidase inhibitor (MAOI). Because irreversible MAOIs permanently deactivate the MAO enzyme, it takes the body approximately two weeks to synthesize new enzyme. Therefore, a strict 14-day washout period is required before initiating any serotonergic medications to avoid life-threatening serotonin syndrome. Since she stopped the medication 3 days ago, she must avoid serotonergic agents for at least 11 additional days.

Step-by-Step Solution

1
Diagnose the primary current condition based on the presenting symptoms.
The patient has generalized anxiety disorder (GAD), characterized by >6 months of pervasive worry across multiple domains, accompanied by somatic symptoms like muscle tension and fatigue.
Establishing the correct current diagnosis determines the baseline treatment algorithm.
2
Analyze the patient's psychiatric history for contraindications to standard pharmacotherapy.
The patient has a history of a manic episode (hospitalization, euphoric mood, hypersexuality, no sleep for 8 days), establishing a background diagnosis of Bipolar I Disorder.
Patients with a history of bipolar disorder are at high risk for antidepressant-induced mania (manic switch) if treated with SSRI/SNRI monotherapy.
3
Evaluate the patient's recent medication history for potential drug-drug interactions.
The patient took phenelzine, an irreversible monoamine oxidase inhibitor (MAOI), and discontinued it 3 days ago.
Irreversible MAOIs permanently deactivate the MAO enzyme. It takes approximately 14 days for the body to synthesize new enzyme, meaning a strict 14-day washout period is required before starting any serotonergic drugs.
4
Synthesize the findings to select appropriate management.
Pharmacotherapy with serotonergic agents is currently absolutely contraindicated (due to the MAOI taken 3 days ago) and relatively contraindicated as monotherapy (due to Bipolar I). The best approaches are psychotherapy (CBT) and strict avoidance of serotonergic drugs for the remaining 11 days of the washout.
Combining these facts ensures patient safety (preventing serotonin syndrome and manic switch) while effectively treating the GAD.

Key Concept

Management of anxiety in the context of comorbid Bipolar I Disorder and recent MAOI use requires prioritizing psychotherapy and adhering to a strict 14-day washout period before considering any serotonergic agents.
Question 676Question →

Match each of the following clinical presentations of childhood psychiatric and neurodevelopmental conditions with the cellular mechanism of action of its indicated first-line pharmacotherapy.

Click a left item, then click its matching right item

Items

A 7-year-old boy with academic underperformance who frequently blurts out answers, leaves his seat during class, and interrupts peers. Parent and teacher behavioral interventions have been unsuccessful.
An 11-year-old boy with a two-year history of repetitive facial grimacing, shoulder shrugging, and involuntary grunting sounds that cause significant distress. Comprehensive behavioral intervention has failed.
A 6-year-old boy who voids in his bed four nights a week and has never achieved nighttime dryness. A trial of a bedwetting alarm and evening fluid restriction for four months has not improved symptoms.
A 9-year-old boy with significant social communication deficits and stereotyped hand-flapping who recently developed severe, self-injurious head-banging and physical aggression refractory to behavioral modifications.

Matches

Show answer & explanation

Answer

ADHD is managed with stimulants (dopamine/norepinephrine reuptake inhibition). Tourette syndrome is managed with alpha-2 agonists (central presynaptic alpha-2 agonism). Enuresis is managed with desmopressin (V2 receptor activation). ASD-associated severe irritability is managed with atypical antipsychotics (D2 and 5-HT2A antagonism).
Each clinical scenario requires a three-step deduction: confirming the diagnosis, identifying the guideline-directed first-line medication post-behavioral failure, and recognizing that medication's specific mechanism of action.

Step-by-Step Solution

1
Diagnose the underlying neurodevelopmental or behavioral condition based on the specific clinical criteria presented in each vignette.
Identified ADHD, Tourette syndrome, primary nocturnal enuresis, and ASD with severe irritability.
Accurate diagnosis is the mandatory first step before considering pharmacological management.
2
Determine the most appropriate first-line medication for each condition, acknowledging that conservative or behavioral therapies have already failed in these scenarios.
Selected stimulants (ADHD), alpha-2 agonists (Tourette), desmopressin (enuresis), and atypical antipsychotics (ASD irritability).
Clinical guidelines dictate specific pharmacological escalations when behavioral interventions are inadequate.
3
Match each selected medication to its corresponding cellular mechanism of action.
Matched each drug class to its receptor or transporter target.
Understanding the pharmacodynamic properties of psychotropic drugs is essential for anticipating therapeutic effects and side effect profiles.

Key Concept

Pharmacological management of childhood neurodevelopmental disorders requires correlating specific diagnostic symptom clusters with targeted neurochemical interventions once behavioral therapies are exhausted.
Question 677Question →

Match each patient's clinical presentation to the most accurate psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A 25-year-old man with a 6-month history of auditory hallucinations and persecutory delusions. During this 24-week period, he experienced a single 3-week episode of severe depressed mood and anhedonia. His mood has been euthymic for the past month, but the hallucinations persist.
A 32-year-old woman with a 2-year history of pervasive auditory hallucinations. Over the past two years, she has had four discrete episodes of major depression, each lasting 3-4 months. Her hallucinations continue even when her mood is completely normal.
A 40-year-old man who has exhibited severe psychomotor retardation, profound guilt, and insomnia for the past 6 weeks. For the last 2 weeks, he has also heard voices telling him he is 'damned.' He had no psychiatric symptoms prior to 6 weeks ago.
A 22-year-old woman presenting with 5 days of decreased need for sleep, pressured speech, and grandiose delusions of being royalty. After treatment with a mood stabilizer, her mood normalizes within 2 weeks, and her delusions completely resolve simultaneously.
A 45-year-old man who is absolutely convinced that his coworkers are monitoring his emails to steal his ideas, a belief he has held for 4 months. He has no hallucinations, negative symptoms, or disorganized speech. He continues to perform well at his job.

Matches

Show answer & explanation

Answer

The correct pairings rely on calculating the temporal relationship and proportional duration of mood symptoms relative to psychotic symptoms.
The correct pairings depend on the precise DSM-5 timeline criteria for psychotic disorders. Major depressive disorder and Bipolar I with psychotic features require psychosis to occur strictly during the mood episode. Schizoaffective disorder requires >2 weeks of isolated psychosis, but mood symptoms must be present for the majority of the total illness. Schizophrenia may have brief mood episodes, but they constitute a minority of the illness duration. Delusional disorder involves isolated delusions without other psychotic features.

Step-by-Step Solution

1
Determine if psychosis occurs exclusively during mood episodes.
If yes, the diagnosis is a primary mood disorder with psychotic features (e.g., MDD or Bipolar I).
Primary mood disorders can manifest psychotic features, but these only occur concurrently with the severe mood disturbance.
2
If psychosis occurs outside of mood episodes, determine the duration of the isolated psychosis.
Psychosis persisting for 2 or more weeks in the absence of mood symptoms indicates a primary psychotic disorder (Schizophrenia or Schizoaffective).
This 2-week criterion is the hallmark requirement for diagnosing schizoaffective disorder and ruling out mood disorders with psychosis.
3
Calculate the proportional duration of mood episodes over the total course of the illness.
If mood symptoms are present for the majority (>50%) of the total illness duration, the diagnosis is schizoaffective disorder. If present for a minority, it is schizophrenia.
The DSM-5 differentiates schizoaffective disorder from schizophrenia strictly based on whether mood symptoms dominate the longitudinal course of the disease.

Key Concept

Differentiating primary psychotic disorders from mood disorders with psychotic features based on the temporal relationship of symptoms.
Estimated Time:2m 0s
Question 678Question →

Match each clinical presentation involving anxiety, stress, or fear-based symptoms to the most appropriate DSM-5 diagnosis based on symptom duration and characteristics.

Click a left item, then click its matching right item

Items

Symptoms including autonomic arousal, intrusive memories, and avoidance of reminders occurring for 3 weeks following a life-threatening motor vehicle collision.
Symptoms of severe distress, flashbacks, negative alterations in cognition, and hypervigilance persisting for 6 months after experiencing a violent assault.
Disproportionate fear and avoidance of highly specific situations, such as flying or heights, enduring for more than 6 months and causing significant impairment.
Marked fear or anxiety about two or more situations, such as using public transportation or being in open spaces, due to thoughts that escape might be difficult.
Development of emotional and behavioral symptoms out of proportion to an identifiable psychosocial stressor (e.g., sudden job loss), occurring within 3 months of the event.

Matches

Show answer & explanation

Answer

The correct matches rely on accurately applying temporal criteria (e.g., 1-month cutoff for trauma responses) and symptom specificity to DSM-5 definitions.
Each presentation matches its respective DSM-5 diagnosis based on specific duration thresholds (e.g., the 1-month cutoff differentiating ASD from PTSD) and phenomenological features (e.g., isolated triggers in specific phobia versus escape-focused environments in agoraphobia).

Step-by-Step Solution

1
Evaluate the clinical presentation related to trauma to distinguish between Acute Stress Disorder and PTSD.
Trauma symptoms lasting 3 weeks align with Acute Stress Disorder (<1 month), while those lasting 6 months align with PTSD (>1 month).
Duration of symptoms is the primary distinguishing factor between these two trauma-related diagnoses.
2
Analyze the nature of the fear or anxiety described to separate Specific Phobia from Agoraphobia.
Fear of isolated stimuli (flying, heights) points to Specific Phobia, whereas fear of multiple environments (open spaces, transit) due to fear of not being able to escape points to Agoraphobia.
Agoraphobia requires fear in at least 2 distinct situations related to escape/help, while Specific Phobia is triggered by specific objects or single distinct situations.
3
Identify the criteria for stress-related emotional changes not meeting full criteria for other disorders.
Symptoms developing within 3 months of a non-life-threatening stressor (like job loss) point to Adjustment Disorder.
Adjustment Disorder serves as a diagnosis for maladaptive reactions to identifiable psychosocial stressors that do not meet criteria for major depressive or severe trauma disorders.

Key Concept

Differentiation of anxiety, trauma, and stressor-related disorders requires careful assessment of symptom duration (e.g., ASD vs. PTSD) and the specific nature of the psychological trigger.
Question 679Question →

Match each clinical presentation or medication adverse effect with the corresponding dopaminergic pathway involved in its pathophysiology.

Click a left item, then click its matching right item

Items

A 23-year-old man with schizophrenia develops severe restlessness and an inability to sit still (akathisia) after starting haloperidol.
A 28-year-old woman with schizophrenia presents with amenorrhea and galactorrhea after several months of treatment with risperidone.
A 22-year-old man is brought to the emergency department experiencing command auditory hallucinations and prominent persecutory delusions.
A 35-year-old man with a long-standing history of schizophrenia exhibits pronounced flat affect, severe social withdrawal, and poverty of speech.

Matches

Show answer & explanation

Answer

Akathisia matches to Nigrostriatal pathway. Galactorrhea matches to Tuberoinfundibular pathway. Positive symptoms (hallucinations/delusions) match to Mesolimbic pathway. Negative symptoms (flat affect) match to Mesocortical pathway.
There are four main dopaminergic pathways relevant to schizophrenia and antipsychotic pharmacology. The mesolimbic pathway is associated with positive symptoms due to excess dopamine. The mesocortical pathway is associated with negative symptoms due to a dopamine deficit. The tuberoinfundibular pathway regulates prolactin; dopamine blockade here causes hyperprolactinemia. The nigrostriatal pathway regulates movement; dopamine blockade here causes extrapyramidal symptoms.

Step-by-Step Solution

1
Identify the primary clinical manifestation in each patient scenario.
Patient 1 has extrapyramidal symptoms (akathisia). Patient 2 has hyperprolactinemia (amenorrhea, galactorrhea). Patient 3 has positive psychotic symptoms (hallucinations, delusions). Patient 4 has negative psychotic symptoms (flat affect, avolition).
Recognizing the specific symptom cluster or medication side effect is necessary to map it to the correct neuroanatomical pathway.
2
Map the positive and negative symptoms of schizophrenia to their respective dopaminergic pathways.
Positive symptoms correlate with mesolimbic hyperactivity. Negative symptoms correlate with mesocortical hypoactivity.
This is the foundational dopamine hypothesis of schizophrenia.
3
Map the adverse effects of antipsychotic medications to their respective dopaminergic pathways.
Extrapyramidal symptoms map to the nigrostriatal pathway. Hyperprolactinemia maps to the tuberoinfundibular pathway.
Antipsychotics block D2 receptors, leading to therapeutic effects in the mesolimbic pathway but off-target adverse effects in the nigrostriatal and tuberoinfundibular pathways.

Key Concept

Dopaminergic pathways in schizophrenia and antipsychotic adverse effects.
Question 680Question →

An emergency department physician evaluates a 29-year-old female patient after police found her wandering in traffic. The patient is highly agitated and states, "The angels are speaking to me, they say the end is coming!" Her sister arrives at the hospital and explains that the patient had been functioning perfectly normally until two weeks ago. At that time, the patient's house was destroyed in a severe fire, and she immediately began exhibiting disorganized speech and reporting auditory hallucinations. She has no prior history of mental illness, and she does not use alcohol or recreational drugs. Vital signs are within normal limits. A thorough medical workup reveals no metabolic, infectious, or neurologic abnormalities. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Brief psychotic disorder

Answer

Brief psychotic disorder
The correct diagnosis is brief psychotic disorder. This condition is characterized by the sudden onset of psychotic symptoms (such as hallucinations, delusions, or disorganized speech) that last for at least 1 day but less than 1 month, eventually resolving completely. This patient's abrupt onset of auditory hallucinations and disorganized speech following a major trauma exactly two weeks ago perfectly meets these criteria.

Step-by-Step Solution

1
Analyze the patient's presenting psychiatric symptoms.
The patient exhibits prominent auditory hallucinations and disorganized speech.
Identifying the core symptoms is necessary to establish the presence of a primary psychotic disorder.
2
Determine the exact duration of the psychotic symptoms.
Collateral history from the sister confirms the symptoms began abruptly exactly two weeks ago following a severe stressor.
Symptom duration is the most critical factor for differentiating between acute psychotic diagnoses.
3
Compare the symptom profile and duration against DSM-5 criteria.
Symptoms lasting between 1 day and 1 month align with brief psychotic disorder. Diagnoses of schizophreniform disorder (1-6 months) and schizophrenia (>6 months) are ruled out.
Applying precise temporal criteria secures the correct diagnosis and prevents premature labeling of a lifelong psychotic illness.

Key Concept

The primary differentiating factor among brief psychotic disorder (<1 month), schizophreniform disorder (1-6 months), and schizophrenia (>6 months) is the total duration of the psychotic symptoms.
PreviousPage 34 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 34 | Examkin